The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The listed pharmaceuticals company has delivered increased revenue and profit despite margins slipping in Australasia.
Investment into North American sales support to broaden customer base outside food transportation sector.
Listed food delivery company’s shares up more than 25% following full-year results announcement.
The group was said to be ‘well positioned’ to continue its path of efficiency and stripping out costs.
NZX-listed port company says smaller cruise vessels will bring fewer passengers and mean less revenue.
Software-as-a-service company's revenues supported by high interest rate environment.
The move brings the number of New Zealand companies solely listed on the ASX to 18.
Legal challenge among options after its hero product was struck off the Medicare subsidy list; by August the company will know more about its fate in the critical US market.
Data centres are hot as AI boosts demand, but One NZ feels corporate spending slump.